Telaprevir therapy, renal impairment, and their effects on the pharmacokinetics of tenofovir in HIV/hepatitis C virus coinfected patients

被引：5
|
作者：
Gervasoni, Cristina [1 ]
Milazzo, Laura [1 ]
Pezzani, Diletta [1 ]
Fucile, Serena [2 ]
Cattaneo, Dario [2 ]
机构：
[1] Luigi Sacco Univ Hosp, Div Infect Dis 3, I-20157 Milan, Italy
[2] Luigi Sacco Univ Hosp, Clin Pharmacol Unit, I-20157 Milan, Italy
来源：
AIDS | 2014年 / 28卷 / 02期
关键词：
KIDNEY; ASSOCIATION; EXPOSURE;
D O I：
10.1097/QAD.0000000000000088
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：285 / 287
页数：3
相关论文
共 50 条
  • [31] Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment
    Elise J. Smolders
    Clara T. M. M. de Kanter
    Bart van Hoek
    Joop E. Arends
    Joost P. H. Drenth
    David M. Burger
    Drug Safety, 2016, 39 : 589 - 611
  • [32] Prevalence of potential interactions between antiretroviral therapy and boceprevir or telaprevir in human immunodeficiency virus-hepatitis C virus coinfected patients
    Gonzalez-Colominas, Elena
    Sola, Ricard
    Barrantes-Gonzalez, Melisa
    Salas, Esther
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2013, 31 (05): : 350 - 351
  • [33] Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment
    Smolders, Elise J.
    de Kanter, Clara T. M. M.
    van Hoek, Bart
    Arends, Joop E.
    Drenth, Joost P. H.
    Burger, David M.
    DRUG SAFETY, 2016, 39 (07) : 589 - 611
  • [34] Efficacy and tolerance of telaprevir in HIV-hepatitis C virus genotype 1-coinfected patients failing previous antihepatitis C virus therapy: 24-week results
    Lacombe, Karine
    Valin, Nadia
    Stitou, Hind
    Gozlan, Joel
    Thibault, Vincent
    Boyd, Anders
    Poirier, Jean-Marie
    Meynard, Jean-Luc
    Valantin, Marc-Antoine
    Bottero, Julie
    Girard, Pierre-Marie
    AIDS, 2013, 27 (08) : 1356 - 1359
  • [35] Advances in Therapy for HIV/Hepatitis C Virus-Coinfected Patients in the Liver Transplant Setting
    Campos-Varela, Isabel
    Peters, Marion G.
    Terrault, Norah A.
    CLINICAL INFECTIOUS DISEASES, 2015, 60 (01) : 108 - 116
  • [36] Acute renal failure and liver toxicity in an HIV/hepatitis C coinfected patient receiving telaprevir and boosted atazanavir
    Van den Eynde, Eva
    Ferrer, Elena
    Podzamczer, Daniel
    AIDS, 2014, 28 (10) : 1538 - 1539
  • [37] Lipid abnormalities in HIV/hepatitis C virus-coinfected patients
    Bedimo, R.
    Ghurani, R.
    Nsuami, M.
    Turner, D.
    Kvanli, M-B
    Brown, G.
    Margolis, D.
    HIV MEDICINE, 2006, 7 (08) : 530 - 536
  • [38] Hepatitis C virus-HIV-coinfected patients and liver transplantation
    Kardashian, Ani A.
    Price, Jennifer C.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2015, 20 (03) : 276 - 285
  • [39] Telaprevir pharmacokinetics in a hepatitis C virus infected patient on haemodialysis
    de Kanter, Clara T. M. M.
    den Hollander, Jan G.
    Verweij-van Wissen, Corrien P. W. G. M.
    Burger, David M.
    JOURNAL OF CLINICAL VIROLOGY, 2014, 60 (04) : 431 - 432
  • [40] Hepatitis C viral kinetics during treatment of hepatitis C virus/HIV coinfected patients
    Zeremski, Marija
    Talal, Andrew H.
    CURRENT OPINION IN HIV AND AIDS, 2007, 2 (06) : 489 - 495
12345